Monoamine Oxidase

• 

  Subject Areas on Research

  • A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. 
  • A comparison of inpatients with primary unipolar depression and depression secondary to anxiety. 
  • A longitudinal study of epigenetic variation in twins. 
  • A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults. 
  • Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression. 
  • Antidepressant drug therapy in psychotic depression. 
  • Association test for X-linked QTL in family-based designs. 
  • Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. 
  • Bad Nature, Bad Nurture, and Testimony Regarding MAOA and SLC6A4 Genotyping in Murder Trials 
  • Biochemical and ultrastructural differences between muco-epidermoid and carcinoid tumors of the bronchus. 
  • Biological and/or genetic factors in alcoholism. 
  • Central nervous system serotonin and clustering of hostility, psychosocial, metabolic, and cardiovascular endophenotypes in men. 
  • Comparison of monoamine oxidase in golden hamster islets and insulinoma. 
  • Dopamine polymorphisms and depressive symptoms predict foods intake. Results from a nationally representative sample. 
  • Effect of delta 9-tetrahydrocannabinol on monoamine oxidase activity in bovine eye tissues, in vitro. 
  • Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice. 
  • Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. 
  • Expression of a copper-containing amine oxidase by human ciliary body. 
  • Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B. 
  • Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. 
  • G protein-coupled receptor kinase-2 (GRK-2) regulates serotonin metabolism through the monoamine oxidase AMX-2 in Caenorhabditis elegans. 
  • Gene-gene interaction between FGF20 and MAOB in Parkinson disease. 
  • Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. 
  • Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. 
  • HPA axis function in male caregivers: effect of the monoamine oxidase-A gene promoter (MAOA-uVNTR). 
  • Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. 
  • Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond. 
  • Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain. 
  • Identification of neurogenetic pathways of risk for psychopathology. 
  • In vitro assays fail to predict in vivo effects of regulatory polymorphisms. 
  • Increased renal dopamine and acute renal adaptation to a high-phosphate diet. 
  • Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. 
  • Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine. 
  • Interactions between genotype and depressive symptoms on obesity. 
  • Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR). 
  • MAO inhibition and control of anxiety following amitriptyline therapy. A pilot study. 
  • MAOA genotype, childhood maltreatment, and their interaction in the etiology of adult antisocial behaviors. 
  • MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. 
  • MAOA-uVNTR and early physical discipline interact to influence delinquent behavior. 
  • Mary Bernheim and the discovery of monoamine oxidase. 
  • Monoamine oxidase A and B activities in liver of riboflavin-deficient rats. 
  • Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. 
  • Monoamine oxidase of rat skeletal muscle: substrate specificity and half-life. 
  • Neural mechanisms of genetic risk for impulsivity and violence in humans. 
  • Obesity is associated with genetic variants that alter dopamine availability. 
  • Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. 
  • Platelet MAO activity in posttraumatic stress disorder. 
  • Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence. 
  • Platelet monoamine oxidase activity and the classification of depression. 
  • Platelet monoamine oxidase activity in schizophrenia. 
  • Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. 
  • Prediction of treatment outcome with lithium. 
  • Prevention of H2O2 generation by monoamine oxidase protects against CNS O2 toxicity. 
  • Problems with diagnostic criteria for depression. 
  • Regional differences in brain monoamine oxidase subtypes in an animal model of geriatric depression: effects of olfactory bulbectomy in young versus aged rats. 
  • Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo. 
  • Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. 
  • Reserpine-like effects of harmine on isolated adrenal medullary vesicles. 
  • Role of genotype in the cycle of violence in maltreated children. 
  • Serotonin-related gene polymorphisms and central nervous system serotonin function. 
  • Single case study. Complementary effects of phenelzine and psychotherapy in long term treatment of depression. 
  • Substrate-dependent activation energy of the reaction catalyzed by monoamine oxidase. 
  • Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease. 
  • The effect of isocarboxazid on platelet MAO activity. 
  • The importance of dose in isocarboxazid therapy. 
  • The new look of behavioral genetics in developmental psychopathology: gene-environment interplay in antisocial behaviors. 
  • The psychobiology of premenstrual dysphoria: review of theories and treatments. 
  • The ureterovesical innervation. A new concept based on a histochemical study. 
  • Toward an animal model for antisocial behavior: parallels between mice and humans. 
  • X-APL: an improved family-based test of association in the presence of linkage for the X chromosome. 
  • X-LRT: a likelihood approach to estimate genetic risks and test association with X-linked markers using a case-parents design.